12 days ago
NBIX
AnalystsJeffrey WalchJeffrey Walch's Stock Forecasts
AnalystsJeffrey Walch
Sectors:
Analyst Ranking
Bottom 36%
#3426 out of 5289 analysts
Average Return
-0.38%
Win Rate
33%1 out of 3
Risk vs Reward
Poor
Good
Jeffrey Walch's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Summit Therapeutics IncSMMT | +10.59% | $16.62 | $14.86 | 2026-05-22 - 2026-06-02 | Sell |
Jeffrey Walch Analyst Color
Get additional color on Jeffrey Walch's coverage of popular stocks
12 days ago
JAZZ
Jeffrey Walch's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Neurocrine Biosciences IncNBIX | 1 | Buy | $221.00 | +42.73% | Initiates Coverage On | 12 days ago |
Incyte CorpINCY | 1 | Hold | $99.00 | +7.33% | Initiates Coverage On | 12 days ago |
Jazz Pharmaceuticals PLCJAZZ | 1 | Hold | $229.00 | +1.27% | Initiates Coverage On | 12 days ago |
Revolution Medicines IncRVMD | 1 | Hold | $151.00 | -0.20% | Initiates Coverage On | 12 days ago |
Biontech SeBNTX | 1 | Hold | $96.00 | +7.70% | Initiates Coverage On | 12 days ago |
Summit Therapeutics IncSMMT | 1 | Sell | $7.70 | -48.18% | Initiates Coverage On | 12 days ago |
Nuvalent IncNUVL | 1 | Buy | $189.00 | +106.90% | Initiates Coverage On | 12 days ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.